International Immunopharmacology, Год журнала: 2024, Номер 129, С. 111639 - 111639
Опубликована: Фев. 9, 2024
Язык: Английский
International Immunopharmacology, Год журнала: 2024, Номер 129, С. 111639 - 111639
Опубликована: Фев. 9, 2024
Язык: Английский
Neuroscience, Год журнала: 2024, Номер 548, С. 9 - 26
Опубликована: Апрель 30, 2024
Язык: Английский
Процитировано
13Heliyon, Год журнала: 2024, Номер 10(1), С. e24050 - e24050
Опубликована: Янв. 1, 2024
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that causes significant neurodegeneration. Methylmercury (MeHg) neurotoxin induces axonal neurodegeneration and motor nerve degeneration by destroying oligodendrocytes, degenerating white matter, inducing apoptosis, excitotoxicity, reducing myelin basic protein (MBP). This study examines the inhibition of SIRT-1 (silence information regulator 1), Nrf-2 (nuclear factor E2-related 2), HO-1 (heme oxygenase TDP-43 (TAR-DNA-binding 43) accumulation in context ALS, as well modulation these proteins icariin (15 30 mg/kg, orally), glycoside flavonoid with neuroprotective properties. Neuroprotective activates SIRT-1, Nrf-2, HO-1, mitigating inflammation neuronal injury disorders. In-vivo in-silico testing experimental ALS models confirmed efficacy modulating cellular targets. The addition sirtinol 10 an inhibitor helps determine effectiveness icariin. In this study, we also examined neurobehavioral, neurochemical, histopathological, LFB (Luxol fast blue) markers various biological samples, including Cerebrospinal fluid (CSF), blood plasma, brain homogenates (Cerebral Cortex, Hippocampus, Striatum, mid-brain, Cerebellum). These results demonstrate administration ameliorates mechanism underlying benefits likely related to regulating signaling pathways.
Язык: Английский
Процитировано
9Multiple Sclerosis and Related Disorders, Год журнала: 2025, Номер 94, С. 106261 - 106261
Опубликована: Янв. 6, 2025
Язык: Английский
Процитировано
1Molecular Neurobiology, Год журнала: 2024, Номер 61(8), С. 5161 - 5193
Опубликована: Янв. 3, 2024
Язык: Английский
Процитировано
7Clinica Chimica Acta, Год журнала: 2024, Номер 556, С. 117841 - 117841
Опубликована: Фев. 22, 2024
Язык: Английский
Процитировано
7Journal of Neuroimmunology, Год журнала: 2023, Номер 384, С. 578200 - 578200
Опубликована: Сен. 16, 2023
Язык: Английский
Процитировано
14Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2024, Номер 397(6), С. 3867 - 3895
Опубликована: Янв. 16, 2024
Язык: Английский
Процитировано
4Advances in protein chemistry and structural biology, Год журнала: 2024, Номер unknown, С. 199 - 248
Опубликована: Янв. 1, 2024
Язык: Английский
Процитировано
4Drug Development Research, Год журнала: 2025, Номер 86(1)
Опубликована: Янв. 5, 2025
ABSTRACT The central nervous system is affected by multiple sclerosis (MS), a chronic autoimmune illness characterized axonal destruction, demyelination, and inflammation. This article summarizes the state of field, highlighting its complexity significant influence on people's quality life. research employs network pharmacological approach, integrating systems biology, bioinformatics, pharmacology to identify biomarkers associated with MS. Utilizing Nelumbo Nucifera (Lotus) seeds, study involves toxicity assessments, biomolecule screening, target prediction. Advanced computational methodologies are employed, including molecular docking dynamic simulations, assess potential therapeutic interactions. Biomolecule screening identifies eight active compounds from Lotus Anonaine Liriodenine. Target prediction reveals 264 common targets MS‐related genes. Protein‐protein interaction analysis establishes complex network, identifying like SRC AKT1. Bioinformatics enrichment uncovers candidates pathways. A Biomolecule‐Target‐Pathway diagram visualizes interactions, Liriodenine exhibiting strong binding affinities in studies. Molecular dynamics simulations provide insights into In conclusion, through advanced techniques, it unveils therapies, pathways, bridging predictions practical applications. show promise curbing MS biomarkers.
Язык: Английский
Процитировано
0Neuroscience, Год журнала: 2025, Номер unknown
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0